Gilead's pill succeeds in mid-stage bowel disease trial | Reuters

Gilead's oral drug succeeds in mid-stage inflammatory bowel disease trial

Gilead Sciences reported that its oral treatment eliminated symptoms in patients with inflammatory bowel disease in a mid-stage clinical trial.